Antipodes Partners’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-460,269
Closed -$26.8M 130
2025
Q2
$26.8M Sell
460,269
-347,576
-43% -$19.6M 0.83% 30
2025
Q1
$40.1M Sell
807,845
-219,447
-21% -$11.2M 1.26% 26
2024
Q4
$46M Buy
1,027,292
+101,515
+11% +$4.82M 1.6% 24
2024
Q3
$44.5M Sell
925,777
-618,728
-40% -$29.8M 1.54% 25
2024
Q2
$78.6M Sell
1,544,505
-501,174
-24% -$27.4M 2.86% 14
2024
Q1
$111M Buy
2,045,679
+450,384
+28% +$23.5M 3.51% 11
2023
Q4
$89.9M Buy
1,595,295
+1,586,631
+18,313% +$89.7M 2.81% 17
2023
Q3
$545K Buy
+8,664
New +$548K 0.02% 45
2023
Q1
Sell
-494,749
Closed -$36.1M 75
2022
Q4
$36.1M Sell
494,749
-232,168
-32% -$18.3M 1.3% 33
2022
Q3
$60.6M Buy
726,917
+109,337
+18% +$9.41M 2.43% 17
2022
Q2
$49.2M Buy
617,580
+161,741
+35% +$15.7M 2.05% 23
2022
Q1
$47.4M Sell
455,839
-125,885
-22% -$10.4M 1.68% 22
2021
Q4
$43.7M Buy
+581,724
New +$40.7M 1.57% 25

Other funds holding NTR